↓ Skip to main content

PLOS

Systemic Inhibition of NF-κB Activation Protects from Silicosis

Overview of attention for article published in PLOS ONE, May 2009
Altmetric Badge

Readers on

mendeley
50 Mendeley
Title
Systemic Inhibition of NF-κB Activation Protects from Silicosis
Published in
PLOS ONE, May 2009
DOI 10.1371/journal.pone.0005689
Pubmed ID
Authors

Michelangelo Di Giuseppe, Federica Gambelli, Gary W. Hoyle, Giuseppe Lungarella, Sean M. Studer, Thomas Richards, Sam Yousem, Ken McCurry, James Dauber, Naftali Kaminski, George Leikauf, Luis A. Ortiz

Abstract

Silicosis is a complex lung disease for which no successful treatment is available and therefore lung transplantation is a potential alternative. Tumor necrosis factor alpha (TNFalpha) plays a central role in the pathogenesis of silicosis. TNFalpha signaling is mediated by the transcription factor, Nuclear Factor (NF)-kappaB, which regulates genes controlling several physiological processes including the innate immune responses, cell death, and inflammation. Therefore, inhibition of NF-kappaB activation represents a potential therapeutic strategy for silicosis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 18%
Student > Master 6 12%
Researcher 5 10%
Professor > Associate Professor 5 10%
Student > Ph. D. Student 5 10%
Other 13 26%
Unknown 7 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 26%
Medicine and Dentistry 12 24%
Immunology and Microbiology 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Nursing and Health Professions 1 2%
Other 6 12%
Unknown 12 24%